Lanzamiento Enero 2027

Ensayo controlado aleatorizado2022Financiado por la industriaAlimentación controladaSolo mecanismos

Financiado en parte por Cobram Estate Pty. Ltd

Extra virgin olive oil high in polyphenols improves antioxidant status in adults: a double-blind, randomized, controlled, cross-over study (OLIVAUS)

Sarapis K, George ES, Marx W, Mayr HL, Willcox J, Esmaili T, Powell KL, Folasire OS, Lohning AE, Garg M, Thomas CJ, Itsiopoulos C, Moschonis G

European journal of nutrition · 33 citas

Etiquetas de revisión

Alimentación controladaFinanciado por la industriaSolo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Solo mecanismos
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiado por la industria
Universidad u hospital
La Trobe University
Empresa
Cobram Estate Pty. Ltd
Universidad u hospital
La Trobe University Understanding Disease Research Focus Area

Según 3 financiadores declarados.

Publicación

Publicado
2021-10-30 · Eur J Nutr · vol. 61 · número 2 · págs. 1073–1086
Editorial
Springer Science+Business Media
Citado
37 citas · más que el 88% de estudios similares · 2.1× el promedio de su campo
Referencias
44 trabajos
Acceso
Acceso abierto (copia en repositorio) · CC-BY
Áreas de investigación
Edible Oils Quality and Analysis · Phytochemicals and Antioxidant Activities · Fatty Acid Research and Health
Palabras clave
extra virgin olive oil, olive oil polyphenols, antioxidant status, oxidative stress, oxidized LDL, total antioxidant capacity, C-reactive protein, inflammation, abdominal obesity, cardiometabolic risk, dietary intervention
MeSH
humans, plant oils, antioxidants, cross-over studies, adult, middle aged, australia, female, male, young adult, polyphenols, olive oil

13 autores

  • Katerina Sarapis🇦🇺La Trobe University
  • Elena S. George🇦🇺Deakin University; La Trobe University
  • Wolfgang Marx🇦🇺Deakin University; La Trobe University
  • Hannah L. Mayr🇦🇺Bond University; La Trobe University; Princess Alexandra Hospital
  • Jane Catherine Willcox🇦🇺Deakin University; The University of Queensland; La Trobe University
  • Tammy Esmaili🇦🇺La Trobe University
  • Katie Powell🇦🇺Bond University
  • Oladayo S. Folasire🇦🇺Bond University
  • Anna Elizabeth Lohning🇦🇺Bond University
  • Manohar L. Garg🇦🇺University of Newcastle Australia
  • Colleen J. Thomas🇦🇺La Trobe University
  • Catherine Itsiopoulos🇦🇺La Trobe University; RMIT University
  • George Moschonis🇦🇺 · autor de correspondenciaLa Trobe University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

Olive oil polyphenols have been associated with cardiovascular health benefits. This study examined the antioxidant and anti-inflammatory effect of extra-virgin high polyphenol olive oil (HPOO) vs. low polyphenol olive oil (LPOO) in healthy Australian adults.

Methods

In a double-blind cross-over trial, 50 participants (aged 38.5 ± 13.9 years, 66% females) were randomized to consume 60 mL/day of HPOO (320 mg/kg polyphenols) or LPOO (86 mg/kg polyphenols) for three weeks. Following a 2-week wash-out period, participants crossed-over to the alternate treatment. Plasma oxidized low-density lipoprotein (ox-LDL), total antioxidant capacity (TAC), high-sensitivity C-reactive protein (hs-CRP) and anthropometrics were measured at baseline and follow-up.

Results

Fourty-three participants completed the study. Although there were no significant differences between treatments in the total sample, plasma ox-LDL decreased by 6.5 mU/mL (95%CI - 12.4 to - 0.5) and TAC increased by 0.03 mM (95% CI 0.006-0.05) only in the HPOO arm. Stratified analyses were also performed by cardiovascular disease risk status defined by abdominal obesity (WC > 94 cm in males, > 80 cm in females) or inflammation (hs-CRP > 1 mg/L). In the subgroup with abdominal obesity, ox-LDL decreased by 13.5 mU/mL (95% CI - 23.5 to - 3.6) and TAC increased by 0.04 mM (95% CI 0.006-0.07) only after HPOO consumption. In the subgroup with inflammation, hs-CRP decreased by 1.9 mg/L (95% CI - 3.7 to -0.1) only in the HPOO arm.

Conclusions

Although there were no significant differences between treatments, the changes observed after HPOO consumption demonstrate the antioxidant and anti-inflammatory effect of this oil, which is more pronounced in adults with high cardiometabolic risk (Clinical Trial Registration: ACTRN12618000706279).

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.